Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

CytoMed Therapeutics Limited

GDTCNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 11, 2026Accepted Aug 11, 2026, 10:37 AM EDTFiling CIK 1873093Accession 0001477932-26-004854
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
CytoMed Therapeutics Ltd
Issuer CIK
0001873093
SEC file number
001-41677
Phone
6562507738
Person for whose account securities are to be sold
mDR Ltd
Relationships to issuer
10% Stockholder
Street
#08-22 ONE COMMONWEALTH
City
1 COMMONWEALTH LANE
State / country code
U0
Postal code
149544

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Ordinary Shares117,337103,256.5611,828,43508/11/2026NASDAQBank of Sinapore

Broker / market maker — proposed row 1, entry 1

Name
Bank of Sinapore
Street
63 Market St, #22-00
City
Singapore
State / country code
U0
Postal code
048942

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Ordinary Shares04/22/2021Share SubscriptionIssuer711,822N04/20/2021Cash

Prior-sale reporting

Nothing to report for the preceding three months
Y

Remarks

Immediately prior to filing this Form 144, mDR Ltd holds 1,221,523 ordinary shares of the Issuer.

Notice signature

Notice date
08/11/2026
Signed
/s/ Edward Lee Ewe Ming

Company context

Current securities

Recent company filings

  1. 6-K filingOct 13, 2026
  2. 6-K filingSep 30, 2026
  3. 6-K filingJun 23, 2026
  4. 6-K filingJun 3, 2026
  5. 6-K filingMay 15, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.